IE
IE · IE · IE-PA-EU/1/22/1714/001-003
Pombiliti 105 mg powder for concentrate for solution for infusion
ATC A16AB23
Last synced from HPRA (Ireland) on
Identification
ManufacturerAmicus Therapeutics Europe Limited
CountryIE (IE)
ATC codeA16AB23
Dispensing—
ReimbursedNo
SourceHPRA (Ireland)
Last synced6/8/2026
Packs · 1
- ie_pa_numberEU/1/22/1714/001-003
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Powder for concentrate for solution for injection/infusion",
"routes": [
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"A16AB",
"A16AB23"
],
"strength": null,
"pa_number": "EU/1/22/1714/001-003",
"substances": [
"Cipaglucosidase alfa"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "20/03/2023",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}Related drugs
Other records sharing ATC code A16AB23.
- 🇨🇭Pombiliti
- ISPombilitiAmicus Therapeutics Europe Limited*
- NOPombilitiAmicus Therapeutics Europe Limited
- PLPombilitiAmicus Therapeutics Europe Limited
- 🇨🇭PombilitiAmicus Therapeutics Switzerland GmbH
- DKPombilitiAmicus Therapeutics Europe Ltd
- FIPombilitiAmicus Therapeutics Europe Limited
- CZPOMBILITIAmicus Therapeutics Europe Limited, Dublin
Access this data programmatically
Query Pombiliti 105 mg powder for concentrate for solution for infusion and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.